Biologic Therapies Aimed at Rheumatoid Arthritis

Home

Category: CME
Sub-Category: RHEU/PHAR
Date: 5/27/2006
Time:2:00 PM to 2:45 PM
Facility: Moscone Convention Center
Location: Gateway Ballroom 102
Description: At the conclusion of this presentation, participants will be able to:
Describe relevant targets for immunomodulatory therapy in rheumatoid arthritis
Explain key risks and benefits of available biologic agents
Define new approaches to treatment for rheumatoid arthritis that are in development

Rheumatoid arthritis (RA) is a systemic inflammatory disease that targets synovial tissues, and if left unchecked, can cause significant morbidity and mortality. Improved understanding of the pathophysiology of RA has resulted in novel treatments such as biological agents which selectively modulate receptors or cells involved in the inflammatory process. Success with agents that target cytokines has changed the approach to therapy and prompted the development of newer biologics. This article will review the currently approved therapies as well as investigational ones directed against other pro-inflammatory cytokines, T-cells, and B-cells.
Speaker(s): Arthur Kavanaugh M.D. 


View Syllabus      

 

Copyright 1998-2006.  American Academy of Physician Assistants.  All rights reserved.